https://www.selleckchem.com/pr....oducts/midostaurin-p
BACKGROUND Frailty disproportionally affects people with HIV (PWH) and increased frailty in this already vulnerable population is associated with worse neurocognitive functioning. Whether frailty interacts with current and modifiable markers of HIV disease severity to synergistically increase risk for HIV-Associated Neurocognitive Disorders (HAND), however, is unknown and important for informing the clinical care of aging PWH. SETTING UC San Diego's HIV Neurobehavioral Research Program METHODS Participants were 178 people wit